Mono-Methyl-Histone H2B (Lys5) Antibody

What is mono-methylation of histone H2B at lysine 5 and what role does it play in chromatin regulation?

Mono-methylation of lysine 5 on histone H2B (H2BK5me1) is a post-translational modification that occurs at active promoters downstream of the transcription start site . This modification contributes to the regulation of chromatin structure and function as part of the histone code. Histone H2B is one of the four core histones that make up the nucleosome core particle, with nucleosomes consisting of approximately 146 bp of DNA wrapped around an octamer comprised of pairs of the four core histones (H2A, H2B, H3, and H4) . The presence of post-translational modifications like H2BK5me1 helps regulate chromatin structure and function, thereby influencing gene expression, DNA repair, and replication .

How does H2BK5me1 differ from other histone H2B modifications at the same residue?

H2BK5me1 is distinct from other modifications that can occur at the same lysine residue:

While acetylation generally correlates with transcriptional activation by reducing the positive charge of histones and potentially weakening histone-DNA interactions, mono-methylation may have more context-dependent effects. These modifications compete for the same residue, suggesting a potential regulatory switch mechanism.

How specific are Mono-Methyl-Histone H2B (Lys5) antibodies, and how can I validate their specificity?

Proper validation of Mono-Methyl-Histone H2B (Lys5) antibodies is crucial for experimental reliability. Recommended validation protocols include:

• Peptide competition assays using modified and unmodified peptides

• Testing against samples with known absence of the modification (e.g., cells with H2BK5 mutated to arginine)

• Comparing reactivity with other H2B modifications at the same residue using peptide arrays

• Performing dot blot assays with different histone peptides containing various modifications

For example, in peptide array validation similar to that described by Cell Signaling Technology, antibodies should be tested against multiple histone modifications to confirm they specifically recognize H2BK5me1 without cross-reacting with unmodified H2B or other modifications . A truly specific antibody will show strong signal with H2BK5me1 peptides but minimal cross-reactivity with other modifications.

What species cross-reactivity can be expected for Mono-Methyl-Histone H2B (Lys5) antibodies?

Based on available data, Mono-Methyl-Histone H2B (Lys5) antibodies typically exhibit cross-reactivity across several species:

What are the optimal protocols for using Mono-Methyl-Histone H2B (Lys5) antibody in Western blotting?

For optimal Western blotting with Mono-Methyl-Histone H2B (Lys5) antibody:

• Sample preparation:

  • Extract histones using acid extraction method (0.2N HCl or 0.4N H₂SO₄)

  • Include histone deacetylase and methyltransferase inhibitors during extraction

• SDS-PAGE:

  • Use 15-18% gels for optimal separation of histones

  • Load 10-20 μg of acid-extracted histones per lane

• Transfer and blocking:

  • Transfer to PVDF membrane (recommended over nitrocellulose)

  • Block with 5% non-fat dry milk in TBST

• Antibody incubation:

  • Dilute primary antibody 1:100-1:500 in blocking buffer

  • Incubate overnight at 4°C

  • Wash thoroughly with TBST (3-5 times, 5 minutes each)

  • Incubate with HRP-conjugated secondary antibody (typically 1:2000-1:5000)

• Detection:

  • Use ECL substrate appropriate for your expected signal intensity

  • Expected molecular weight for histone H2B is approximately 14 kDa

For optimal results, include positive controls such as HeLa acid extracts from sodium butyrate-treated cells , which increase histone acetylation levels and provide a good reference point.

How can I optimize Chromatin Immunoprecipitation (ChIP) experiments with Mono-Methyl-Histone H2B (Lys5) antibody?

Optimizing ChIP experiments with Mono-Methyl-Histone H2B (Lys5) antibody requires attention to several critical factors:

• Crosslinking and chromatin preparation:

  • Crosslink cells with 1% formaldehyde for 10 minutes at room temperature

  • Sonicate chromatin to obtain fragments of 200-500 bp

  • Ensure consistent fragmentation by checking on agarose gel

• Immunoprecipitation:

  • Use 5-10 μg of antibody per ChIP reaction

  • For optimal results, use 10 μg of chromatin (approximately 4 x 10⁶ cells) per IP

  • Pre-clear chromatin with protein A/G beads

  • Incubate antibody-chromatin mixture overnight at 4°C

• Washing and elution:

  • Use stringent washing conditions with increasing salt concentrations

  • Reverse crosslinks (65°C overnight) and purify DNA

  • Use RNase and Proteinase K treatment to remove RNA and protein contaminants

• Controls and validation:

  • Include IgG negative control

  • Include positive control antibody targeting well-characterized marks (e.g., H3K4me3)

  • Validate enrichment by qPCR at known target regions before proceeding to sequencing

The antibody has been validated for ChIP-seq in studies by consortiums like modENCODE and NIH Roadmap Epigenomics Mapping , supporting its utility for genome-wide profiling of H2BK5me1 distribution.

What are common issues encountered when using Mono-Methyl-Histone H2B (Lys5) antibody and how can they be resolved?

Researchers often encounter several challenges when working with Mono-Methyl-Histone H2B (Lys5) antibody:

For Western blot applications, consider the specific recommendations for antibody dilution (typically 1:100-1:500 for H2BK5me1 antibodies) and verify the extraction method is preserving the modification of interest.

How do different cell fixation and extraction methods affect the detection of H2BK5me1?

The choice of fixation and extraction methods significantly impacts H2BK5me1 detection:

• Histone extraction methods:

  • Acid extraction (0.2N HCl or 0.4N H₂SO₄) is preferred for Western blot applications as it efficiently isolates histones while preserving methylation marks

  • Direct lysis in SDS sample buffer often results in lower histone yield and potential loss of modifications

  • RIPA buffer extraction may not efficiently solubilize chromatin-bound histones

• Fixation for immunofluorescence/immunohistochemistry:

  • Paraformaldehyde (4%, 10 minutes) works well for maintaining nuclear architecture

  • Methanol fixation (-20°C, 10 minutes) can preserve methylation marks effectively

  • For tissue sections, antigen retrieval may be necessary to expose the epitope (citrate buffer pH 6.0)

• ChIP considerations:

  • Formaldehyde crosslinking time should be optimized (8-12 minutes typically)

  • Over-crosslinking can mask epitopes and reduce antibody accessibility

  • Native ChIP (without crosslinking) may be suitable for some histone modifications but requires careful handling

When comparing results across different experimental approaches, it's important to consider how the preparation method might affect epitope accessibility and modification stability.

How should H2BK5me1 distribution patterns be interpreted in relation to gene expression?

When analyzing H2BK5me1 distribution patterns:

• Genomic localization patterns:

  • H2BK5me1 is typically enriched at active promoters downstream of transcription start sites

  • Compare distribution with other active marks (H3K4me3, H3K27ac) to confirm association with active genes

  • Examine correlation with gene expression levels from RNA-seq data

• Expected distribution profile:

  • Enrichment should be observed primarily in euchromatic regions

  • Strong signals at transcriptionally active regions

  • Potential enrichment at development-related genes in certain cell types

• Functional interpretation:

  • Increased H2BK5me1 at promoters generally correlates with active transcription

  • Changes in H2BK5me1 levels during cellular processes may indicate regulatory transitions

  • Absence at expected loci might suggest competing modifications (such as acetylation at the same residue)

According to Wozniak and Strahl (2014), "mono-methylation of lysine 5 is thought to occur at active promoters downstream of the transcription start site" , providing a foundation for interpreting genomic distribution patterns.

How can I distinguish between H2BK5me1 and other histone H2B modifications in multi-omics studies?

Distinguishing between similar histone modifications requires careful experimental design:

• Antibody validation strategies:

  • Use peptide competition assays with specific modified peptides

  • Conduct dot blot analyses with synthetic peptides containing different modifications

  • Include samples with known modification states (e.g., cells treated with histone deacetylase inhibitors like sodium butyrate )

• Sequential ChIP (Re-ChIP) approach:

  • First immunoprecipitate with one antibody (e.g., general H2B)

  • Re-immunoprecipitate the eluate with H2BK5me1-specific antibody

  • This confirms co-occurrence on the same nucleosomes

• Mass spectrometry validation:

  • Use MS to quantitatively assess modification levels

  • MS can distinguish between mono-, di-, and tri-methylation as well as acetylation

  • Use heavy isotope-labeled peptide standards for accurate quantification

• Integrative analysis:

  • Correlate H2BK5me1 patterns with other histone marks

  • Compare with DNA methylation and chromatin accessibility data

  • Validate key findings with orthogonal approaches (e.g., reporter assays)

H2BK5me1 has a distinct functional profile from H2BK5ac, with the latter being more broadly associated with active transcription and enhanced by histone deacetylase inhibitors .

How can mass spectrometry complement antibody-based detection of H2BK5me1?

Mass spectrometry offers several advantages over antibody-based methods for analyzing H2BK5me1:

For H2BK5me1 specifically, MS can help resolve questions about its co-occurrence with other modifications on the same histone molecule and provide accurate quantification of relative abundance compared to other H2B modifications.

What approaches can be used to identify the enzymes responsible for writing and erasing H2BK5me1?

Identifying the enzymatic machinery regulating H2BK5me1 requires systematic approaches:

• Candidate approach for writer/eraser identification:

  • Screen known lysine methyltransferases using in vitro assays with recombinant H2B

  • Conduct siRNA/shRNA knockdown of candidate enzymes and assess H2BK5me1 levels

  • Perform CRISPR-Cas9 knockout of promising candidates

  • Use small molecule inhibitors of methyltransferases and observe effects on H2BK5me1

• Unbiased discovery methods:

  • Affinity purification using modified H2B peptides as bait

  • Proximity labeling approaches with modified nucleosomes

  • Genetic screens (e.g., CRISPR) with H2BK5me1 levels as readout

  • Proteomic analysis of H2B-associated proteins in different cellular states

• Validation strategies:

  • Reconstitute enzymatic activity in vitro with purified components

  • Rescue experiments in knockout cells

  • Structure-function analysis of candidate enzymes

  • Temporal analysis of enzyme activity and H2BK5me1 levels

• Reader protein identification:

  • Similar approaches can identify proteins that specifically recognize H2BK5me1

  • Focus on proteins containing methyl-lysine binding domains (e.g., PHD fingers, chromo domains)

  • Validate interactions using biochemical and cellular approaches

Understanding the complete regulatory machinery will provide insights into how H2BK5me1 is dynamically regulated in different cellular contexts.

How can CRISPR-based approaches be used to study the functional significance of H2BK5me1?

CRISPR-based strategies offer powerful ways to investigate H2BK5me1 function:

• Direct histone mutation approaches:

  • Generate CRISPR knock-in cell lines with H2B K5R mutation (prevents methylation)

  • Create H2B K5Q mutation (mimics some aspects of acetylation)

  • Produce homozygous mutant cell lines through multiple rounds of editing

  • Assess phenotypic and transcriptomic consequences

• Epigenome editing strategies:

  • Use dCas9 fused to methyltransferases to increase H2BK5me1 at specific loci

  • Deploy dCas9-demethylase constructs to remove H2BK5me1 at target sites

  • Analyze resulting changes in chromatin structure and gene expression

  • Compare effects with other modifications at the same residue (e.g., H2BK5ac)

• Manipulation of regulatory enzymes:

  • Create CRISPR knockouts of putative writers, erasers, and readers

  • Develop inducible degradation systems for temporal control

  • Implement CRISPR activation/interference to modulate expression of regulatory machinery

When studying histone modifications in yeast models, direct manipulation of the H2B gene is particularly feasible since S. cerevisiae contains just two genes (HTB1 and HTB2) that code for histone H2B, making it easier to create loss-of-function alleles .

What emerging technologies are improving our ability to study histone modifications like H2BK5me1?

Several cutting-edge technologies are enhancing histone modification research:

• Single-cell epigenomics:

  • CUT&Tag/CUT&RUN methods with higher sensitivity for low cell numbers

  • Single-cell ChIP-seq adaptations for histone modifications

  • Integration with single-cell transcriptomics for correlation analysis

  • These approaches will reveal cell-to-cell heterogeneity in H2BK5me1 distribution

• Long-read sequencing applications:

  • Direct detection of modifications on native chromatin

  • Linking distant regulatory elements through long-read technologies

  • Phasing of multiple modifications on the same nucleosome

• Advanced imaging approaches:

  • Super-resolution microscopy of histone modifications

  • Live-cell imaging using modification-specific intrabodies

  • Spatial mapping of histone modifications in tissue contexts

• Combinatorial epigenetic profiling:

  • Simultaneous profiling of multiple histone marks from the same sample

  • Integration of chromatin accessibility, DNA methylation, and histone modifications

  • Multi-modal single-cell approaches

For example, CUT&Tag-IT technology offered by companies like Active Motif provides improved signal-to-noise ratio for profiling histone modifications compared to traditional ChIP-seq, potentially allowing detection of H2BK5me1 with greater sensitivity and from fewer cells.

What are the most critical unanswered questions about H2BK5me1 biology?

Despite progress in studying H2BK5me1, several fundamental questions remain:

• Enzymatic machinery:

  • Which specific methyltransferases write H2BK5me1?

  • Which demethylases remove this modification?

  • How is their activity regulated in different cellular contexts?

• Functional significance:

  • What is the precise role of H2BK5me1 in transcription regulation?

  • How does it interact with other histone modifications?

  • Are there specific reader proteins that recognize H2BK5me1?

• Disease relevance:

  • Is H2BK5me1 dysregulated in specific diseases?

  • Could targeting its regulatory machinery offer therapeutic opportunities?

  • Does it serve as a biomarker for particular cellular states?

• Evolutionary conservation:

  • How conserved is H2BK5me1 function across species?

  • Are there species-specific aspects of its regulation and function?

• Developmental dynamics:

  • How does H2BK5me1 change during development and differentiation?

  • What role does it play in cellular memory and epigenetic inheritance?